Vaccine Immunogenicity to SARS-CoV-2 in Renal Transplant Patients Under Three Different Immunosuppressive Regimens: Evaluation of Antibody Titers
Transplantation Proceedings · 2026
DOI: 10.1016/j.transproceed.2026.06.029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplantation Proceedings, 2026. Verfasst von Marcelo Paes Menezes Filho und 8 weiteren Autor:innen. Beteiligte Einrichtung: Kidney Transplantation Service, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, São Paulo, Brazil. Electronic…. Hauptthemen laut MEDLINE: Kidney Transplantation, Immunosuppressive Agents, Immunogenicity, Vaccine, COVID-19. Die Arbeit nennt 13 Literaturangaben. Gefördert von: State of Sao Paulo Research Foundation.
Abstract (Originalsprache)
BACKGROUND: In kidney transplant recipients (KTRs), the immunogenic response to vaccines is considered to be low in achieving a robust immune response. METHODS: This study evaluated the serological response of KTRs who received previous immunization with the anti-SARS-CoV-2 vaccine ChAdOx1 and 2 booster doses of BNT162b2 vaccine. Patients were on 3 different immunosuppressive regimens: azathioprine (AZA), mycophenolic acid precursors (MPA), or mammalian target of rapamycin inhibitors (mTORi). All were also on tacrolimus and prednisone. Healthy volunteers served as controls. Blood samples were collected before receiving the first booster dose, 4 to 6 weeks after the first booster dose, and 6 months after the second booster dose. RESULTS: Before the vaccine booster, the MPA group had a tendency, but not statistically significant, of a lower reactivity rate than the AZA, mTORi, and control groups. The percentage of reactivity was AZA 54%, MPA 42%, mTORi 55%, and controls 73%, respectively. After the first booster, the serological response had a significant increase, indicating the effectiveness of the heterologous vaccine dose in all groups (P < .05 in percentage of responders in serological titers), which reached the following percentage of seroreactivity: AZA 90%, MPA 80%, mTORi 88%, and controls 100%, respectively. After the second booster dose, seroreactivity was 81%, 91%, and 100%, respectively. CONCLUSIONS: After the vaccine booster, there was no statistically significant difference in IgG titers among the AZA, MPA, and mTORi groups in KTRs that demonstrated that the additional booster regimen with BNT162b2 increased the initial low responsiveness, increasing seroconversion rates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Kidney Transplantation Service, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, São Paulo, Brazil. Electronic address: marcelo.filho@fbpn-campos.com.br.
- Kidney Transplantation Service, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, São Paulo, Brazil.
- Medical Investigation Laboratory (LIM56). Department of Dermatology. Faculdade de Medicina da Universidade de São Paulo, São Paulo, São Paulo, Brazil.
Förderung
- State of Sao Paulo Research Foundation
Zitieren
APA
Menezes Filho, M. P., de Azevedo, L. S. F., da Silva, L. T., Fernandes, J. R., Sumida, T. O., Trevisan, B., Agena, F., Davi-Neto, E., & Bernard, G. (2026). Vaccine Immunogenicity to SARS-CoV-2 in Renal Transplant Patients Under Three Different Immunosuppressive Regimens: Evaluation of Antibody Titers. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2026.06.029
Vancouver
Menezes Filho MP, de Azevedo LSF, da Silva LT, Fernandes JR, Sumida TO, Trevisan B, et al. Vaccine Immunogenicity to SARS-CoV-2 in Renal Transplant Patients Under Three Different Immunosuppressive Regimens: Evaluation of Antibody Titers. Transplantation Proceedings. 2026. doi:10.1016/j.transproceed.2026.06.029
BibTeX
@article{MenezesFilho2026,
author = {Menezes Filho, Marcelo Paes and de Azevedo, Luiz Sergio Fonseca and da Silva, Lais Teodoro and Fernandes, Juliana Ruiz and Sumida, Telma Oshiro and Trevisan, Beatriz and Agena, Fabiana and Davi-Neto, Elias and Bernard, Gil},
title = {Vaccine Immunogenicity to SARS-CoV-2 in Renal Transplant Patients Under Three Different Immunosuppressive Regimens: Evaluation of Antibody Titers},
journal = {Transplantation Proceedings},
year = {2026},
doi = {10.1016/j.transproceed.2026.06.029}
}
EUVIMED